Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
STLE Annual MeetingSTLE Annual Meeting
Not Confirmed
Not Confirmed
18-22 May, 2025
Not Confirmed
Not Confirmed
19-22 May, 2025
Not Confirmed
Not Confirmed
20-22 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
STLE Annual MeetingSTLE Annual Meeting
Industry Trade Show
Not Confirmed
18-22 May, 2025
Industry Trade Show
Not Confirmed
19-22 May, 2025
Industry Trade Show
Not Confirmed
20-22 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions
26 Apr 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/fda-puts-vyne-twist-slapping-hold-psoriasis-trial-over-testicular-toxicity
20 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/20/3046158/0/en/VYNE-Therapeutics-to-Participate-in-the-H-C-Wainwright-3rd-Annual-Autoimmune-Inflammatory-Disease-Virtual-Conference.html
06 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/06/3038147/0/en/VYNE-Therapeutics-Reports-2024-Fourth-Quarter-and-Year-End-Financial-Results-and-Provides-Business-Update.html
20 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/20/3029569/0/en/VYNE-Therapeutics-to-Participate-in-March-Investor-Conferences.html
19 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/02/19/3028700/0/en/VYNE-Therapeutics-Initiates-Phase-1b-Trial-of-VYN202-a-Novel-BD2-Selective-Oral-BET-Inhibitor-in-Plaque-Psoriasis.html
06 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/06/3004503/0/en/VYNE-Therapeutics-Completes-Enrollment-in-Phase-2b-Trial-Evaluating-VYN201-for-the-Treatment-of-Nonsegmental-Vitiligo.html
ABOUT THIS PAGE